Markets:

Overview

News

Currencies

International

Treasuries

InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

1.430 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about InMed Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

In today's session, these stocks are experiencing unusual volume. ↗

November 20, 2025

On Thursday, there are stocks with unusual volume. Let's take a look.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 20, 2025

Via Benzinga

Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗

November 20, 2025

Via Benzinga

What's Driving InMed's (INM) 22% After-Hours Surge? ↗

November 20, 2025

InMed shares jumped 22% in after-hours trading after the company reported encouraging large-animal study results for its Alzheimer's drug candidate INM-901.

Via Benzinga

Get insights into the top gainers and losers of Monday's after-hours session. ↗

July 14, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data ↗

July 04, 2025

Cognition Therapeutics Inc (NASDAQ: CGTX) continued to gain 12.10% in after-hours trading on Thursday, after a 20.82% surge during regular market hours.

Via Benzinga

Here are the top movers in Tuesday's session. ↗

June 24, 2025

Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Curious about the most active stocks on Tuesday? ↗

June 24, 2025

Stay updated with the latest market activity on Tuesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

June 24, 2025

Looking for insights into the US markets in the middle of the day on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Which stocks are gapping on Tuesday? ↗

June 24, 2025

The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Why InMed's Alzheimer's Drug Candidate Is Fueling Sudden Stock Surge ↗

June 24, 2025

InMed stock jumped after preclinical data showed INM-901 lowered brain inflammation tied to Alzheimer's and improved cognitive function in models.

Via Benzinga

Tuesday's pre-market session: top gainers and losers ↗

June 24, 2025

Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 24, 2025

Via Benzinga

Which stocks are experiencing notable movement on Monday? ↗

June 02, 2025

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings ↗

June 02, 2025

Via Benzinga

Topics Stocks

Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket ↗

June 02, 2025

Via Benzinga

Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

January 22, 2025

Via Benzinga

Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise ↗

January 21, 2025

The positive trial results propelled InMed into the top 25 trending stocks on Stocktwits, with a flood of bullish comments on the platform.

Via Stocktwits

Crude Oil Down 2%; D.R. Horton Earnings Top Views ↗

January 21, 2025

Via Benzinga

Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing ↗

January 21, 2025

InMed Pharmaceuticals shares are trading higher by 45% during Tuesday's session. The company announced that INM-901 reduced Alzheimer 's-related inflammation in a preclinical study.

Via Benzinga

Dow Jumps 200 Points; 3M Posts Upbeat Q4 Results ↗

January 21, 2025

Via Benzinga

Topics Stocks

Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

August 22, 2024

Via Benzinga

Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

August 21, 2024

Via Benzinga

Crude Oil Falls; Palo Alto Networks Shares Jump After Q4 Earnings ↗

August 20, 2024

Via Benzinga

Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings ↗

August 20, 2024

Via Benzinga

InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday ↗

August 20, 2024

InMed Pharmaceuticals advances INM-901 as an oral treatment for Alzheimer's. Preclinical studies show the small molecule drug achieves effective brain levels, offering a promising alternative to...

Via Benzinga

US Stocks Mixed; Lowe's Cuts FY24 Forecast ↗

August 20, 2024

Via Benzinga

The Rising Importance Of Minor Cannabinoids In The Growing Edible Market

July 19, 2024

The Rising Importance Of Minor Cannabinoids In The Growing Edible Market

Via News Direct

Topics Cannabis

7 F-Rated Growth Stocks to Avoid Right Now: June 2024 ↗

June 28, 2024

A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.

Via InvestorPlace

Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 06, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.